Phase I/Ii Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Targeted Oncology - France
doi 10.1007/s11523-016-0467-0
Full Text
Open PDFAbstract
Available in full text
Date
December 9, 2016
Authors
Publisher
Springer Science and Business Media LLC